• Confirm
  • .
2016/02/21 | Zou Chi
Breast Cancer Vaccine Trials Prove Scientific Success, But Not Legal
The results of a blind trial on a newly developed breast cancer vaccine, OBI-822, bear scientific and medical importance, but the drug is not allowed a permit under current regulations because it did not pass clinical trials. If OBI-822 passes future trials, Taiwan would be the first country in the world to develop a carbohydrate-based vaccine for breast cancer.
2015/11/12 | Yang
Taiwan-US Research Team Announces Major Breakthrough in Cancer Spread
National Taiwan University Hospital's Breast Center Director Huang Jun-sheng says that most of the failed treatments result from the spread of the cancer to vital organs such as the brain, lung and liver. So far there is no possibility for patients suffering from metastasis to survive for a long time.